BROWN PHILIP M 4
4 · LEXICON PHARMACEUTICALS, INC./DE · Filed Feb 17, 2010
Insider Transaction Report
Form 4
BROWN PHILIP M
SVP Clinical Development
Transactions
- Tax Payment
Common Stock
2010-02-12$1.91/sh−5,632$10,757→ 27,306 total - Award
Restricted Stock Units (Phantom Stock)
2010-02-15+26,300→ 26,300 total→ Common Stock (26,300 underlying) - Award
Stock Option (Right to Buy)
2010-02-15+200,000→ 200,000 totalExercise: $1.90Exp: 2020-02-15→ Common Stock (200,000 underlying)
Footnotes (4)
- [F1]Withholding of a portion of vested shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F2]Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/15/2011) and vests 1/48th per month for each month of service thereafter.
- [F3]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F4]Restricted stock units vest with respect to 100% of the shares subject to the restricted stock unit upon the dosing of the first patient in a pivotal human clinical trial in any country, the results of which could be used to establish safety and efficacy of a pharmaceutical product discovered or developed by the Company (whether or not licensed by the Company to a third party) as a basis for a New Drug Application with the U.S. Food and Drug Administration or that would otherwise satisfy the requirements of 21 CFR 321.21(c) or its foreign equivalent.